https://carolinaurologicresearchcenter.com/wp-content/uploads/Dr-shore-screenshot_5-261.jpg250300CURC/wp-content/uploads/logo-1.pngCURC2015-05-26 12:51:022015-05-26 12:51:02Identifying Appropriate Patients for Active Immunotherapy in Prostate Cancer
https://carolinaurologicresearchcenter.com/wp-content/uploads/Dr-shore-screenshot_5-261.jpg250300CURC/wp-content/uploads/logo-1.pngCURC2015-05-26 12:27:242015-05-26 12:48:22Mechanism of Action of Poxvirus-Based Active Immunotherapy
https://carolinaurologicresearchcenter.com/wp-content/uploads/The-prostrate-thumb1.jpg250300CURC/wp-content/uploads/logo-1.pngCURC2015-05-26 12:01:372015-05-26 12:48:53Safety of Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer Previously Treated With Docetaxel: Expanded Access in North America
https://carolinaurologicresearchcenter.com/wp-content/uploads/DrShore-interview-thumb1.jpg250300CURC/wp-content/uploads/logo-1.pngCURC2015-05-22 14:45:032015-05-22 14:49:14Dr. Shore on the TERRAIN Trial for Prostate Cancer
https://carolinaurologicresearchcenter.com/wp-content/uploads/CCR-thumb.jpg250300CURC/wp-content/uploads/logo-1.pngCURC2015-04-30 09:45:362015-04-30 09:45:36A randomized phase II trial of sipuleucel-T with concurrent vs sequential abiraterone acetate plus prednisone in metastatic castration resistant prostate cancer
https://carolinaurologicresearchcenter.com/wp-content/uploads/science-direct-thumb2.jpg250300CURC/wp-content/uploads/logo-1.pngCURC2015-04-30 08:44:042015-04-30 09:48:53Radium-223 Dichloride for Metastatic Castration-resistant Prostate Cancer
https://carolinaurologicresearchcenter.com/wp-content/uploads/LUGPA.jpg250300CURC/wp-content/uploads/logo-1.pngCURC2015-04-29 19:49:362015-04-29 19:51:03May 2015 / Dr. Shore appointed president-elect of LUGPA
https://carolinaurologicresearchcenter.com/wp-content/uploads/clinical-thumb.jpg250300CURC/wp-content/uploads/logo-1.pngCURC2015-04-23 16:02:392015-04-23 16:02:39Combining Immunotherapy and Radiation for Prostate Cancer
https://carolinaurologicresearchcenter.com/wp-content/uploads/euro-urology-thumb1.jpg250300CURC/wp-content/uploads/logo-1.pngCURC2015-04-23 16:00:022015-04-29 15:50:55Efficacy Outcomes by Baseline Prostate-specific Antigen Quartile in the AFFIRM Trial
